@article{DissemondAssadianGerberetal.2011,
  author    = {J. Dissemond and O. Assadian and V. Gerber and A. Kingsley and A. Kramer and D.J. Leaper and G. Mosti and A. Piatkowski de Grzymala and G. Riepe and A. Risse and M. Romanelli and R. Strohal and J. Traber and A. Vasel-Biergans and T. Wild and T. Eberlein},
  title     = {Classification of Wounds at Risk and Their Antimicrobial Treatment with Polihexanide: A Practice-Oriented Expert Recommendation},
  series   = {Skin Pharmacology and Physiology},
  volume    = {24},
  number    = {5},
  publisher = {S. Karger AG},
  address   = {Basel, Switzerland},
  issn      = {1660-5527},
  doi       = {10.1159/000327210},
  url       = {https://nbn-resolving.org/urn:nbn:de:gbv:9-opus-30856},
  pages     = {245 -- 255},
  year      = {2011},
  abstract  = {Currently, there are no generally accepted definitions for wounds at risk of infection. In clinical practice, too many chronic wounds are regarded as being at risk of infection, and therefore many topical antimicrobials – in terms of frequency and duration of use – are applied to wounds. Based on expert discussion and current knowledge, a clinical assessment score was developed. The objective of this wounds at risk (W.A.R.) score is to allow decision-making on the indication for the use of antiseptics on the basis of polihexanide. The proposed clinical classification of W.A.R. shall facilitate the decision for wound antisepsis and allow an appropriate general treatment regimen with the focus on the prevention of wound infection. The W.A.R. score is based on a clinically oriented risk assessment using concrete patient circumstances. The indication for the use of antiseptics results from the addition of differently weighted risk causes, for which points are assigned. Antimicrobial treatment is justified in the case of 3 or more points.},
  language  = {en}
}